 "Galaxy Surfactants extends fall after Tarapur plants receive Form 483")
Galaxy Surfactants dipped 2% to Rs 1,400, extending its past three days 5% decline after the company received Form 483 for two of its facilities in Maharashtra after United States Food and Drug Administration (USFDA) audit.
“The company's two of the facilities (M3 & N46) at Tarapur (Maharashtra) have undergone USFDA inspection which was concluded on March 30, 2018. This is the first USFDA inspection and they issues Form 483 with total 13 observations. The M3 facility received 4 and N46 facility received 9 observations,” Galaxy Surfactants said in a regulatory filing.
All the observations are procedural in nature and none of them are related to any data integrity. The company is in midst to providing a comprehensive response to the observations and would be replying to the USFDA within the stipulated time, it added.
These facilities manufacture two products, Octyl Methoxy Cinnamate and Octocrylene, which have USP monograph. The company said the revenue from the US market for these products is less than 1% of the consolidated revenues and company not expect any financial impact of the same.
“The company's two of the facilities (M3 & N46) at Tarapur (Maharashtra) have undergone USFDA inspection which was concluded on March 30, 2018. This is the first USFDA inspection and they issues Form 483 with total 13 observations. The M3 facility received 4 and N46 facility received 9 observations,” Galaxy Surfactants said in a regulatory filing.
All the observations are procedural in nature and none of them are related to any data integrity. The company is in midst to providing a comprehensive response to the observations and would be replying to the USFDA within the stipulated time, it added.
These facilities manufacture two products, Octyl Methoxy Cinnamate and Octocrylene, which have USP monograph. The company said the revenue from the US market for these products is less than 1% of the consolidated revenues and company not expect any financial impact of the same.
Galaxy Surfactants have five manufacturing facilities India, one located at Taloja (Maharashtra), three located at Tarapur (Maharashtra) and one located at Jhagadia (Gujarat).
The stock was trading at its lowest level since listing on February 8, 2018, fallen 17% as compared to 2% decline in the S&P BSE Sensex during the period.
Galaxy Surfactants raised Rs 9,370 million through initial public c offer (IPO) was subscribed 19.96 times. A manufacturer of specialty chemicals had made a decent debut, as the scrip got listed at Rs 1,698 on BSE, a premium of 15% over its issue price of Rs 1,480.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%